In mid-September, Novo Nordisk inked a pair of deals worth a total of more than $1.1 billion in research and development (R&D ...

The obesity-drug hype that fueled huge gains in Novo Nordisk A/S looks to be running out of steam.Most Read from ...

Sen. Bernie Sanders’ aggressive targeting of Danish drugmaker Novo Nordisk’s Ozempic and Wegovy pricing, and not Eli Lilly’s ...

Novo Nordisk stock fell after a JPMorgan analyst said sales of its blockbuster weight-loss drug may be weaker-than-expected.

On Capitol Hill lawmakers grilled the CEO of the company that makes popular weight loss drugs Ozempic and Wegovy.

Semaglutide belongs to a class of prescription medications that mimic a hormone your body naturally produces after you eat. This hormone helps your pancreas make insulin, which lowers your blood sugar ...

Novo Nordisk’s Wegovy has shown promising benefits in treating a common, chronic skin condition hidradenitis suppurative (HS) ...

First-ever DehydraTECH-processed tirzepatide from Zepbound® to be tested in a swallowed oral format KELOWNA, BC / ACCESSWIRE ...

With 890 million people affected globally and 42% of American adults classified as obese, the allure of a "miracle" weight ...

Semaglutide – a key ingredient in Ozempic and Wegovy – was associated with a lower risk of opioid overdose in patients with Type 2 diabetes and opioid use disorder, research shows.

A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...

People are seeking out 'microdoses' of Ozempic and other weight-loss drugs. Medical professionals say there's pros and cons.